Hyun A. Jung
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 135 publications
Early On-Treatment Host Fitness Dynamics Refine Prognostic Stratification in Advanced NSCLC Receiving First-Line Immunotherapy.
Journal: Cancer research and treatment
Published: June 07, 2026
Central Nervous System Activity of Lazertinib in EGFR-Mutated NSCLC With Prior EGFR TKI Exposure: A Pooled Analysis of KCSG-LU20-15 and LU21-01.
Journal: Thoracic cancer
Published: June 03, 2026
Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional Study.
Journal: JCO global oncology
Published: April 10, 2026
Long-term comparative effectiveness of tepotinib versus standard of care for MET exon 14 skipping-mutated non-small cell lung cancer.
Journal: Therapeutic advances in medical oncology
Published: March 26, 2026
Paired ctDNA analysis reveals diverse resistance mechanisms to mobocertinib in EGFR exon 20 insertion NSCLC.
Journal: Frontiers in oncology
Published: March 11, 2026
Erlotinib plus bevacizumab in EGFR-amplified metastatic solid tumors: results from the KOSMOS I, II study of molecular profiling-guided therapy in advanced cancers.
Journal: International journal of clinical oncology
Published: December 04, 2025
Molecular epidemiology and outcomes of EGFR exon 20 insertion in Korean patients with non-small cell lung cancer.
Journal: Translational lung cancer research
Published: November 30, 2025
Phase II Efficacy and Safety of Pembrolizumab with Platinum Based Chemotherapy in Non-Small Cell Lung Cancer Patients with Untreated, Asymptomatic Brain Metastasis (PHOEBS).
Journal: Cancer research and treatment
Published: October 10, 2025
Artificial intelligence-powered spatial analysis of tumor microenvironment in patients with non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitor.
Journal: Journal for immunotherapy of cancer
Published: September 30, 2025
The Implication of Failure Patterns After Neoadjuvant Chemoradiation Therapy With Small Involved Field in Esophageal Squamous Cell Carcinoma.
Journal: Practical radiation oncology
Published: September 29, 2025
Emerging EGFR-Targeted Therapy in Head and Neck Cancer: A Review.
Journal: JAMA oncology
Published: September 25, 2025
The role of APOBEC in early-stage epidermal growth factor receptor-mutant non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 24, 2025
Last Updated: 09/26/2026